1Vilst rup H. Amodio P. Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by t he American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology, 2014,60: 715- 735.
2Rahimi RS. Singal AG, Cuthbert JA,et al. Lactulose vs polyethylene glycol 3350-electrolyte solution for treatment of overt hepatic encephalopathy: the HELP randomized clinical trial. JAMA Intern Med.2014. 174: 1727-1733.
3Cordoba J. New assessment of hepatic encephalopathy. J Hepatol. 2011.54: 1030-1040.
4Bajaj JS, Cordoba J, Mullen KD, et al. Review article: the design of clinical trials in hepatic encephalopathy-an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISH E"J) consensus statement. Aliment Pharrnacol Ther.2011 ,33: 739-747.
5Hammer HF, Santa Ana CA, Schiller LR, et al, Studies of osmotic diarrhea induced in normal subjects by ingestion of polyethylene glycol and lacrulose, J Clin Invest .1989.84: 1056-1062.
6Abu Hossain S, Chaudhry FA. Zahedi K, et al. Cellular and molecular basis of increased arnmoniagenesis in potassium deprivation. Am J Physiol Renal Physiol , 20 II .30 I : F969-F978.
7Gorkiewicz G, Thallinger GG, Trajanoski S, et al. Alterations in the colonic microbiota in response to osmotic diarrhea. PLoS One. 2013,8: e55817.
8van Berlo CL. van Leeuwen PA, Soeters PB. Porcine intestinal ammonia liberation. Influence of food intake. lacrulose and neomycin trearment.J Hepatol,1988,7:250-257.
